SCHEMBL19627014

SCHEMBL19627014

COc1sc(C)nc1-c1ccc(Cl)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.51
HPGD P15428 1/20 0.51
PTGDR2 Q9Y5Y4 3/20 0.51
PTGS1 P23219 2/20 0.49
PTGS2 P35354 2/20 0.49
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
ALOX5 P09917 2/20 0.41
F2RL3 Q96RI0 1/20 0.40
DHODH Q02127 1/20 0.40
HTT P42858 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
APEX1 P27695 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19625403 0.80 PTGDR2 (0.38) ALDH1A1PTGDR2PTGS2MEN1KMT2A
SCHEMBL19627032 0.80 CYP1A2 (0.40) PTGDR2MEN1KMT2AALOX5F2RL3
SCHEMBL2090659 0.79 ALDH1A1 (0.61) ALDH1A1HPGDPTGDR2PTGS1PTGS2
SCHEMBL791528 0.77 PTGDR2 (0.61) ALDH1A1HPGDPTGDR2PTGS1PTGS2
SCHEMBL19626744 0.76 PTGDR2 (0.53) ALDH1A1HPGDPTGDR2PTGS1PTGS2
SCHEMBL2090657 0.76 PTGDR2 (0.53) ALDH1A1HPGDPTGDR2PTGS1PTGS2
SCHEMBL6631658 0.75 PTGDR2 (0.51) ALDH1A1HPGDPTGDR2PTGS1PTGS2
SCHEMBL6492363 0.74 PTGDR2 (0.55) ALDH1A1HPGDPTGDR2PTGS1PTGS2
SCHEMBL19626751 0.74 PTGDR2 (0.66) ALDH1A1HPGDPTGDR2PTGS1PTGS2
SCHEMBL7841482 0.72 PTGS2 (0.65) ALDH1A1PTGDR2PTGS1PTGS2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators WNT1, WNT3A, CTNNB1 ALDH1A1 1166/4885HPGD 1547/4885PTGDR2 443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.